Castleman’s disease (CD) is an uncommon disorder of the lymphoid hyperplasia. It is especially rare in the retroperitoneum or perirenal area. We report the case of a 62-year-old woman who had an abdominal mass localized above the right kidney in the region of the right adrenal gland found by computed tomography scan. The patient subsequently underwent an exploratory laparotomy. Pathological examination revealed retroperitoneal localized CD (LCD) of the hyaline vascular type. Diversity of disease sites and nonspecificity of clinical manifestations lead to diagnostic difficulties. Therefore, diagnosis is mainly achieved via lymph node biopsy or pathological examination. Like in the reported case, LCD usually has a good prognosis after complete resection of the lesion.

Keywords:
Lymphoid hyperplasia, Castleman’s disease, Laparotomy
1.
Castleman B, Iverson L, Menendez VP: Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 1956;9:822–830.
2.
Menenakos C, Braumann C, Hartmann J, Jacobi CA: Retroperitoneal Castleman’s tumor and paraneoplastic pemphigus: report of a case and review of the literature. World J Surg Oncol 2007;5:45.
3.
Shringarpure S, Sivaraman PB, Parmeswaran A: Castleman’s disease: a rare differential diagnosis for retroperitoneal tumors. Urol Ann 2010;2:44–45.
4.
Cronin DM, Warnke RA: Castleman disease: an update on classification and the spectrum of associated lesions. Adv Anat Pathol 2009;16:236–246.
5.
van Rhee F, Stone K, Szmania S, Barlogie B, Singh Z: Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy. Clin Adv Hematol Oncol 2010;8:486–498.
6.
Bucher P, Chassot G, Zufferey G, Ris F, Huber O, Morel P: Surgical management of abdominal and retroperitoneal Castleman’s disease. World J Surg Oncol 2005;3:33.
7.
Casquero A, Barroso A, Fernández Guerrero ML, Górgolas M: Use of rituximab as a salvage therapy for HIV-associated multicentric Castleman disease. Ann Hematol 2006;85:185–187.
8.
Miltenyi Z, Toth J, Gonda A, Tar I, Remenyik E, Illes A: Successful immunomodulatory therapy in Castleman disease with paraneoplastic pemphigus vulgaris. Pathol Oncol Res 2009;15:375–381.
9.
Sobas MA, Alonso Vence N, Diaz Arias J, Bendaña Lopez A, Fraga Rodriguez M, Bello Lopez JL: Efficacy of bortezomib in refractory form of multicentric Castleman disease associated to POEMS syndrome (MCD- POEMS variant). Ann Hematol 2010;89:217–219.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.